5262-63-5 Usage
Description
Benzothiazole, 2,4-dimethyl(6CI,7CI,8CI,9CI) is an organic compound belonging to the benzothiazole family, characterized by a fusion of a benzene ring and a thiazole ring. It is a white solid with distinct chemical properties that make it suitable for various applications.
Uses
Used in Photographic Industry:
Benzothiazole, 2,4-dimethyl(6CI,7CI,8CI,9CI) is used as a precursor for the preparation of quaternary salts of chalcogenites, which serve as photographic sensitizers. These sensitizers enhance the light sensitivity of photographic emulsions, allowing for improved image quality and faster processing times.
Chemical Properties:
Benzothiazole, 2,4-dimethyl(6CI,7CI,8CI,9CI) is a white solid, which indicates its stability and suitability for use in various chemical reactions and applications. Its specific properties, such as solubility and reactivity, contribute to its effectiveness in the photographic industry.
Check Digit Verification of cas no
The CAS Registry Mumber 5262-63-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,2,6 and 2 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 5262-63:
(6*5)+(5*2)+(4*6)+(3*2)+(2*6)+(1*3)=85
85 % 10 = 5
So 5262-63-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H9NS/c1-6-4-3-5-8-9(6)10-7(2)11-8/h3-5H,1-2H3
5262-63-5Relevant articles and documents
RODENTIA ANIMAL REPELLENT
-
Paragraph 0034, (2016/10/27)
PROBLEM TO BE SOLVED: To provide a repellent having a superior repellent activity for Rodentia animals, and a repellent method for Rodentia animals. SOLUTION: A Rodentia animal repellent contains, as an active ingredient, a compound represented by the for
ANTI-CANCER COMPOUNDS
-
Page/Page column 76; 77, (2015/02/02)
Provided are methods and compositions for the treatment of diseases such as cancer. In certain aspects, compounds which can inhibit Skp2 are provided. Specifically chromenone derivatives are disclosed that have the capability toward reducing differentiation of pluripotent, multipotent or totipotent cells and thus have therapeutic utility in the treatment of a proliferative disease such as cancer.
